Federica Manno
Papers
1
Total Citations
3
H-Index
1
About
Federica Manno has established herself as a leading voice in urologic oncology, with a focused expertise in robotic-assisted surgery and intraoperative imaging. Her primary research centers on optimizing surgical outcomes for renal cell carcinoma, particularly through the innovative application of near-infrared fluorescence (NIRF) with Indocyanine Green (ICG) during robot-assisted partial nephrectomy (RAPN). Manno’s major contribution is a landmark systematic review and meta-analysis that rigorously evaluated the role of NIRF-ICG in enhancing tumor localization, achieving negative surgical margins, and preserving renal function. This work, which has already garnered 3 citations since its 2025 publication, provides the highest level of evidence to date, demonstrating that NIRF-ICG significantly reduces ischemia time and improves selective arterial clamping. Her research has direct clinical implications, offering surgeons a real-time, precision tool to minimize nephron loss. By synthesizing data from controlled studies, Manno has not only validated the safety and efficacy of this technology but also established a new benchmark for intraoperative guidance in nephron-sparing surgery. Her work is essential reading for any urologist or researcher seeking to advance the frontiers of minimally invasive, functional renal preservation.
Research Focus
Key Achievements
Top Papers
- 1